New York State Common Retirement Fund
ITRM

New York State Common Retirement Fund’s Iterum Therapeutics ITRM Stock Holding History

New York State Common Retirement Fund’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,217
Closed -$49K – 3246
2020
Q1 		$49K Buy
1,217
+17
+1% +$715 ﹤0.01% 2986
2019
Q4 		$81K Hold
1,200
– – ﹤0.01% 3050
2019
Q3 		$104K Buy
1,200
+141
+13% +$13.7K ﹤0.01% 3017
2019
Q2 		$109K Sell
1,059
-34
-3% -$3.78K ﹤0.01% 3064
2019
Q1 		$132K Sell
1,093
-67
-6% -$6.14K ﹤0.01% 2878
2018
Q4 		$87K Sell
1,160
-50
-4% -$4.73K ﹤0.01% 2990
2018
Q3 		$122K Hold
1,210
– – ﹤0.01% 3007
2018
Q2 		$198K Buy
+1,210
New +$218K ﹤0.01% 2878

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.59B AUM 21.24% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

New York State Common Retirement Fund's ITRM Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Iterum Therapeutics (ITRM) in Q2 2020, closing a stake of 1,217 shares — an estimated $49K sold.

New York State Common Retirement Fund first reported a position in ITRM in Q2 2018 and held it in 8 quarters. The position peaked at $198K in Q2 2018. 10 funds tracked by Wall St. Rank hold ITRM as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Iterum Therapeutics position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,217 Iterum Therapeutics shares in Q2 2020, an estimated $49K.
  • New York State Common Retirement Fund first reported a position in Iterum Therapeutics in Q2 2018 and held it in 8 quarters.
  • New York State Common Retirement Fund's Iterum Therapeutics position peaked at $198K in Q2 2018.
  • 10 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.